Pier 88 Investment Partners’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
RCMNY
MCMC
AIM
NAMA
Pier 88 Investment Partners's ADPT Position: Q2 2024 in Review
Pier 88 Investment Partners sold out of Adaptive Biotechnologies (ADPT) in Q2 2024, closing a stake of 26,415 shares — an estimated $84.8K sold.
Pier 88 Investment Partners first reported a position in ADPT in Q2 2020 and held it in 16 quarters. The position peaked at $1.2M in Q3 2020. 176 funds tracked by Wall St. Rank hold ADPT as of Q2 2024.
- Pier 88 Investment Partners reported no remaining Adaptive Biotechnologies position as of Q2 2024 after selling out during the quarter.
- Pier 88 Investment Partners sold 26,415 Adaptive Biotechnologies shares in Q2 2024, an estimated $84.8K.
- Pier 88 Investment Partners first reported a position in Adaptive Biotechnologies in Q2 2020 and held it in 16 quarters.
- Pier 88 Investment Partners's Adaptive Biotechnologies position peaked at $1.2M in Q3 2020.
- 176 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2024.
Based on Pier 88 Investment Partners's 13F filing for Q2 2024, filed 6 Aug 2024.